Marketbeat analyst rating abbv
Web9 apr. 2024 · AbbVie ( NYSE:ABBV - Get Rating) last issued its quarterly earnings data on Thursday, February 9th. The company reported $3.60 earnings per share for the quarter, beating analysts' consensus estimates of $3.54 by $0.06. AbbVie had a return on equity of 154.52% and a net margin of 20.39%. Web9 apr. 2024 · According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $161.12. AbbVie Stock Up 0.5 % ABBV stock opened at $161.55 on Friday....
Marketbeat analyst rating abbv
Did you know?
Web11 apr. 2024 · Tue., April 11, 2024 MarketBeat Concord Wealth Partners cut its holdings in AbbVie Inc. ( NYSE:ABBV - Get Rating) by 35.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,854 shares of the company's stock after selling 1,025 shares during the period. Web1 dag geleden · Those are the issues that JNJ hopes to highlight next week when it delivers what is widely expected to be a solid earnings report. Analysts’ expectations are for …
Web14 apr. 2024 · Austin Private Wealth LLC raised its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 22.0% during the fourth quarter, HoldingsChannel reports. The firm owned 2,620 shares of the company’s stock after acquiring an additional 472 shares during the quarter. Austin Private Wealth LLC’s holdings in AbbVie were worth $423,000 at the end … Web9 mrt. 2024 · Nine analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has give AbbVie Inc. (NYSE:ABBV - Get Rating) has been assigned …
Web14 apr. 2024 · According to data from MarketBeat, AbbVie currently has an average rating of "Hold" and a consensus price target of $162.94. AbbVie Stock Performance BioNTech Is Ripe For A Rebound In 2024 Shares of ABBV stock opened at $162.69 on Friday. The business has a fifty day moving average of $154.37 and a 200 day moving average of … Web8 apr. 2024 · The stock has a market capitalization of $285.00 billion, a P/E ratio of 24.44, a price-to-earnings-growth ratio of 3.64 and a beta of 0.58. The business's 50-day simple …
Web11 apr. 2024 · AbbVie stock price quote (NYSE: ABBV), historical charts, related news, stock analyst insights and more to help you make the right investing decisions.
Web31 jul. 2024 · Analyst Ratings Average price target from ratings: $ Average score: Sell Under Hold Over Buy Full Ratings Peers Name Chg % Market Cap Johnson & Johnson … can you hallucinate from being tiredWeb3 apr. 2024 · Nine research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to th Shares of AbbVie Inc. … can you hallucinate with bipolarWeb12 apr. 2024 · Ten analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $161.29. Insider Activity at … can you hallucinate on methWeb11 apr. 2024 · Concord Wealth Partners cut its holdings in AbbVie Inc. (NYSE:ABBV - Get Rating) by 35.6% during the fourth quarter, according to its most recent disclosure with … can you hallucinate when drunkWeb13 apr. 2024 · According to 34 analysts, the average rating for ABBV stock is "Buy." The 12-month stock price forecast is $167.15, which is an increase of 3.58% from the latest … can you hallucinate from alcoholWeb9 apr. 2024 · MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 … can you hallucinate from hypothermiaWeb9 apr. 2024 · AbbVie ( NYSE:ABBV – Get Rating) last announced its quarterly earnings results on Thursday, February 9th. The company reported $3.60 EPS for the quarter, beating analysts’ consensus estimates... brightplan financial